Use of Kenvue Inc.’s Nicorette QuickMist nicotine replacement therapy (NRT) device provides “statistically significant and fast relief” of urges to vape, according to a recently published study funded by the firm.
Kenvue Vaping Cessation Study: Nicorette QuickMist Provides ‘Significant And Fast’ Relief
Use of Kenvue’s Nicorette QuickMist nicotine replacement therapy device resulted in “statistically significant reductions in urges to vape as soon as 30 seconds and up to two hours after dosing compared with placebo,” according to a recently published study funded by the firm.